Open Access

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

  • Deborah JL Wong1,
  • Lidia Robert1, 8,
  • Mohammad S Atefi1,
  • Amanda Lassen1,
  • Geetha Avarappatt1, 7,
  • Michael Cerniglia1,
  • Earl Avramis1,
  • Jennifer Tsoi2,
  • David Foulad1,
  • Thomas G Graeber2,
  • Begonya Comin-Anduix3, 4,
  • Ahmed Samatar5,
  • Roger S Lo2, 4, 6 and
  • Antoni Ribas1, 2, 3, 4Email author
Contributed equally
Molecular Cancer201514:128

https://doi.org/10.1186/s12943-015-0393-2

Published: 2 July 2015

The original article was published in Molecular Cancer 2014 13:194

Correction

After publication of this work [1], we noted that we repeatedly had a typo mistake across the manuscript. The compound we used to test our cell lines was SCH772984 and not SCH722984. The typo was found misspelled in 54 occasions, including the title.

We also wanted to add an affiliation detail to the author’s list, as noted above.

We regret the mistake and upload this note to clarify it.

Notes

Authors’ Affiliations

(1)
Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA)
(2)
Department of Molecular and Medical Pharmacology, UCLA
(3)
Department of Surgery, Division of Surgical-Oncology, UCLA
(4)
Jonsson Comprehensive Cancer Center at UCLA
(5)
Discovery Oncology Merck Research Laboratories, Merck Research Laboratories
(6)
Department of Medicine, Division of Dermatology, UCLA
(7)
University of Applied Sciences
(8)
Universitat Autonoma de Barcelona, UAB

Reference

  1. Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M. Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma. Mol Cancer. 2014;13:194. doi:https://doi.org/10.1186/1476-4598-13-194.PubMed CentralPubMedView ArticleGoogle Scholar

Copyright

© Wong et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement